Abstract
OBJECTIVE: Autosomal dominant hypocalcemia (ADH) is a rare familial or sporadic syndrome associated with activating mutations in the calcium sensing receptor (CaSR) gene. The aim of this study was to assess the functional significance of a novel CaSR mutation and, moreover, to present the clinical characteristics and the bone mineral density (BMD) progression from early childhood to late puberty in a patient with ADH. DESIGN: Genetic analysis of the CaSR gene was performed in a patient who presented in the neonatal period with hypocalcemic seizures and biochemical features of ADH. The functional impact of the novel mutation identified was assessed in cultured HEK 293T cells, transfected with either the wild type (WT) or mutant CaSR, by evaluating intracellular calcium ([Ca2+]i) influx after stimulation with extracellular calcium (Ca2+). Several BMD measurements were performed during the patient’s follow-up until late puberty. RESULTS: A novel CaSR mutation (p.L123S) was identified, which, as demonstrated by functional analysis, renders CaSR more sensitive to extracellular changes of Ca2+ compared with the WT, although the difference is not statistically significant. BMD measurements, from early childhood to late puberty, revealed high normal to elevated BMD. CONCLUSION: We present the first Greek patient, to our knowledge, with sporadic ADH due to a novel gain-of-function mutation of the CaSR gene.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Pearce SH, Williamson C, Kifor O, et al, 1995 A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 335: 1115–1122.
Nesbit MA, Hannan FM, Howies SA, et al, 2013 Mutations affecting G-protein subunit α11 in hypercalcemia and hypocalcemia. N Engl J Med 368: 2476–2486.
Raue F, Pichl J, Dörr HG, et al, 2011 Activating mutations in the calcium-sensing receptor: genetic and clinical spectrum in 25 patients with autosomal dominant hypocalcaemia — A German survey. Clin Endocrinol (Oxf) 75: 760–765.
Hendy GN, Guarnieri V, Canaff L, 2009 Calcium-sensing receptor and associated diseases. Prog Mol Biol Transi Sci 89: 31–95.
Sargent JD, Stukel TA, Kresel J, Klein RZ, 1993 Normal values for random urinary calcium to creatinine ratios in infancy. J Pediatr 123: 393–397.
Papazafiri P, Bossi M, Meldolesi J, 1994 Expression of muscle calsequestrin in epithelial HeLa cells: distribution and functional role. Biochim Biophys Acta 1223: 333–340.
Hu J, Spiegel AM, 2007 Structure and function of the human calcium-sensing receptor: insights from natural and engineered mutations and allosteric modulators. J Cell Mol Med 11: 908–922.
Jensen AA, Spalding TA, Burstein ES, et al, 2000 Functional importance of the Ala(116)-Pro(136) region in the calcium-sensing receptor. Constitutive activity and inverse agonism in a family C G-protein-coupled receptor. J Biol Chem 275: 29547–29555.
Clarke BL, 2014 Bone disease in hypoparathyroidism. Arq Bras Endocrinol Metabol 58: 545–552.
Ficcadenti A, Zallocco F, Neri R, Giovannini L, Tirabassi G, Balercia G, 2015 Bone density assessment in a cohort of pediatric patients affected by 22q11DS. J Endocrinol Invest 38: 1093–1098.
Cianferotti L, Gomes AR, Fabbri S, Tanini A, Brandi ML, 2015 The calcium-sensing receptor in bone metabolism: from bench to bedside and back. Osteoporos Int 26: 2055–2071.
Pearce SH, Bai M, Quinn SJ, Kifor O, Brown EM, Thakker RV, 1996 Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells. J Clin Invest 98: 1860–1866.
Theman TA, Collins MT, Dempster DW, et al, 2009 PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation. J Bone Miner Res 24: 964–973.
Kim MY, Tan AH, Ki CS, et al, 2010 Autosomal dominant hypocalcemia caused by an activating mutation of the calcium-sensing receptor gene: the first case report in Korea. J Korean Med Sci 25: 317–320.
Sørheim JI, Husebye ES, Nedrebø BG, et al, 2010 Phenotypic variation in a large family with autosomal dominant hypocalcaemia. Horm Res Paediatr 74: 399–405.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Papadopoulou, A., Gole, E., Melachroinou, K. et al. Clinical characterization of a novel calcium sensing receptor genetic alteration in a Greek patient with autosomal dominant hypocalcemia type 1. Hormones 16, 200–204 (2017). https://doi.org/10.14310/horm.2002.1734
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.14310/horm.2002.1734